Abstract P4-12-06: Quantification of HER2-driven signaling (HER2S) inhibition of four different anti-HER2 drugs testedex vivoin live primary HER2-negative breast cancer cell samples with abnormal HER2 signaling activity

2017 ◽  
Author(s):  
L Laing ◽  
D Burns ◽  
Y Huang ◽  
I MacNeil ◽  
B Rich ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Cell ◽  
Breast Cancer Cell ◽  
Her2 Signaling ◽  
Signaling Activity

scholarly journals Development of a test that measures real-time HER2 signaling function in live breast cancer cell lines and primary cells

BMC Cancer ◽  
2017 ◽  
Vol 17 (1) ◽  
Author(s):  
Yao Huang ◽  
David J. Burns ◽  
Benjamin E. Rich ◽  
Ian A. MacNeil ◽  
Abhijit Dandapat ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Real Time ◽  
Cell Lines ◽  
Cancer Cell ◽  
Breast Cancer Cell ◽  
Cancer Cell Lines ◽  
Breast Cancer Cell Lines ◽  
Primary Cells ◽  
Signaling Function ◽  
Her2 Signaling

Abstract 639: Inhibition of HER2 signaling using targeted therapeutics in breast cancer cell lines

2011 ◽  
Author(s):  
James Korkola ◽  
Nora Bayani ◽  
Brian Cooper ◽  
Laura M. Heiser ◽  
Paul T. Spellman ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cell Lines ◽  
Cancer Cell ◽  
Breast Cancer Cell ◽  
Cancer Cell Lines ◽  
Breast Cancer Cell Lines ◽  
Targeted Therapeutics ◽  
Her2 Signaling

Combination of Oncolytic Adenoviral Therapy with Chemotherapy for Enhanced Breast Cancer Cell Killing – Virotherapy in combination with chemotherapy

2008 ◽  
Vol 68 (S 01) ◽  
Author(s):  
J Jung ◽  
A Nedeljkovic-Kurepa ◽  
B Glover ◽  
DT Curiel ◽  
RK Schmutzler ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Cell ◽  
Breast Cancer Cell ◽  
Cell Killing
Sign in / Sign up

Export Citation Format

Share Document